FDA Seeks Applications For Patient Engagement Collaborative

FDA and the Clinical Trials Transformation Initiative (CTTI) are requesting applications from patient advocates interested in participating in the agency’s Patient Engagement Collaborative, which aims to engage diverse patient representatives in conversations about medical product development and regulation. The Collaborative has 16 members and employs staggered membership terms. Eight members will be replaced in fall 2024, with new members selected by FDA and CTTI. Membership is open to patients who have a personal experience with a disease or medical condition,...